Med­ic­aid com­mis­sion to Con­gress: In­crease re­bates for ac­cel­er­at­ed ap­proval drugs

As the FDA con­tin­ues to ap­prove more new drugs un­der its ac­cel­er­at­ed ap­proval path­way, the non-par­ti­san Med­ic­aid and CHIP Pay­ment and Ac­cess Com­mis­sion (MAC­PAC) is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER